2nd Summit of the Israeli Society for HealthTech

Cofounder and Chair of the Israeli Society for HealthTech, Maccabi Healthcare Services board member.

Founding Partner and CEO, Almeda Ventures

Professor Emeritus, Faculty of Health Sciences, Ben Gurion University of the Negev
Co-Founder, Dia Imaging Analysis

Director of the School of Medicine, Reichman University (currently under development)

CEO, MindUP

Managing Director, Asensus Surgical Israel

VP Marketing at Pulsenmore – Home Ultrasound.

MedTech executive with extensive experience in medical innovation. Proven track record in building commercial and marketing strategy and developing market access for innovative technologies.  

Driven by passion to positively impact human lives with healthcare innovation and make a real difference in the way care is delivered worldwide.

Amir Amedi is a Professor at Reichman University, Israel. He has founded and directs The Baruch Ivcher Institute for Brain, Cognition & Technology, The Ruth and Meir Rosental Brain Imaging Centre and The Clinical Neuro Immunology Institute.  He is a co-inventor on >10 Patents and the co-founder and Chief Scientist of REMEPY. Amir’s multidisciplinary expertise spans computational neuroscience, brain imaging, and neurology and immunology. His research, featured in top journals like Nature, Forbes and Wire, has earned him prestigious awards, including The Krill Prize from the Wolf Foundation and the James S. McDonnell Foundation Scholar Award, alongside multiple ERC grants.

Head of the Inpatient Oncology Department at the Helmsley Cancer Center, Shaare Zedek, Jerusalem.

A specialist in medical oncology and radiation therapy and a member of the Israeli Oncology Association Committee.

Serves as Head of Oncology at Meuhedet HMO and as the national consultant of oncology at the National Insurance Institute.

Lecturer at the Hadassah Academic College and Ashkelon Academic College in the field of medical risk management, law, medicine and ethics.

Former head of medical risk management at Leumit HMO, international pharmaceutical company medical advisor and long-standing teaching experience in the field of medical education. Was involved in several startup innovative projects and Hackathons.

Gal Atarot is Managing Partner and Co-founder of Edge Medical Ventures and CTO of MEDX Xelerator for the past 7 years. He is also a board member in several MEDX portfolio companies.

Gal is a veteran of the medtech industry, with over 20 years of experience. Previously, he led the research and development group at Medical Surgery Technologies (MST).

Before that, he spent 10 years in an elite technological unit within the IDF’s Intelligence Corps, specializing in electro-optical systems, R&D team leadership, and project management.

Gal holds a BSc in Mechanical Engineering (cum laude) and an ME in Biomedical Engineering, both from the Technion-Israel Institute of Technology.

Professor Dina Ben-Yehuda, MD, is an internationally recognized physician-scientist, hematologist and investigator in hematological malignancies research. She is the director of the Hematology Division at Hadassah University Medical Center and former Dean of the Faculty of Medicine, Hebrew University of Jerusalem. A graduate of the Ben-Gurion University Health Sciences Faculty, Ben-Yehuda completed her internship in internal medicine and hematology at Hadassah and post-graduate studies at the Center for Cancer Research at Memorial Sloan-Kettering in New York. She is treating patients with hematological malignancies and is leading innovative research in the treatment of malignant lymphoma using innovative approaches in combination with extensive clinical work. She is the leader of the Jerusalem Center for Computational Precision Medicine and Co-founder of the Sagol Program for Computational Medicine at The Faculty of Medicine.

Dr. Anat Boehm-Cagan is the Head of Regulatory Strategy and Partnerhips at the Medical Technology, Health Information, Innovation and Research Directorate (MTIIR), of the Israel Ministry of Health (IMoH). The Directorate serves as the main regulator for medical technologies in Israel. As part of her role, Dr. Boehm-Cagan oversees all regulatory partnerships and collaborations, in an effort to encourage and promote regulatory harmonization. For the past year, Dr. Boehm-Cagan has been leading the team focused on designing the regulatory framework for AIaMD/SaMD in collaboration with the Digital Health Division of the IMoH, as well as the Bioconvergence regulatory pathway in collaboration with the Israeli Innovation Authority.

Dr. Boehm-Cagan has a PhD in Neurobiology from Tel Aviv University, and a Master's degree in Public Policy from the Hebrew University in Jerusalem. She is a graduate of the Israeli Civil Service Cadet Program and the 8400 executive health network. 

Dr. Yaron Daniely is a General Partner at aMoon Fund, where he co-leads Velocity, aMoon's early-stage investment fund. Prior to aMoon, Yaron was President and CEO of Yissum, Hebrew University’s Technology Transfer Company, and Co-Chairperson of the Israel Technology Transfer Network. Before leading Yissum, he spent 14 years as a senior executive of private and NASDAQ-traded Biotech companies. Yaron earned his PhD from NYU, served as a Visiting Fellow at the NIH, and as an American Cancer Society Postdoctoral Fellow at The Weizmann Institute for Science in Israel. He also holds an MBA from the Technion.

Dr. Talya Dor is a pediatric neurologist at Hadassah Medical Center. She directs the pediatric neuromuscular service, and specializes in novel therapies for Duchenne and Becker muscular dystrophies.

Einat is a professional serving as an Outsource Manager at the Rafael R&D Center in Tel Aviv. With a robust educational background from Technion and UCI Merage, Einat has honed a diverse skill set tailored to the demands of the high-tech and biotech industries.

Einat’s expertise spans across both strategic planning and hands-on implementation, with seed startups and large companies alike.

In addition to her professional endeavors, Einat is dedicated to giving back to the community. She actively volunteers with Restart Global, where she contributes to developing technical solutions for injured IDF soldiers, enabling them to navigate their daily lives more effectively.

Moti Freiman is an assistant professor of biomedical engineering at the Technion–Israel Institute of Technology. He is the director of the Technion’s computational MRI lab and the academic director of the May-Blum-Dahl human MRI research center at the Technion. In addition, he is a principal computer vision engineer at Asensus Surgical LTD, a Karl Storz company.

Previously he was a staff research scientist at Philips Healthcare, an Instructor of Radiology at Harvard Medical School, and a post-doctoral fellow at the Computational Radiology lab at Boston Children’s Hospital. Dr. Freiman holds a PhD in Computer Science from the Hebrew University of Jerusalem. His main research interests include AI-based methods for medical imaging. Dr. Freiman has more than 50 scientific papers in peer-reviewed journals and conferences and more than 10 granted patents.

Dr. Nadav Goldental is a psychiatrist and the Head of the Neurodevelopmental Disorders in Adults Clinic at Sheba Medical Center, specializing in Autism, ADHD, and Intellectual Disabilities. He leads cutting-edge research in digital mental health, focusing on EEG wearables and smart biochemical sensors for innovative diagnostic and therapeutic technologies. Dr. Goldental holds a B.Sc. in Electrical Engineering from Technion and an MBA in Healthcare Innovation from Reichman University. He also directs Innomind, a research lab dedicated to digital psychiatry and innovation in psychiatry.  

Uri Goren is a strategic leader with over 15 years of experience in driving innovation and digital transformation in the pharmaceutical and healthcare industries. As Head of Innovation at Meir Medical Center, Clalit Health Services, he is developing strategic plans, strengthening partnerships, and leading teams to foster a culture of entrepreneurship. His previous roles include leading digital engagement at Teva Pharmaceuticals and founding e-Pochonder, where he developed the first Hebrew crowd-sourced patient assistance app for diabetes. Uri also contributes to the National Committee for Digital Health and has published works on innovative business models and participatory medicine.   

Liat Gottlieb was appointed Managing Director of Johnson & Johnson Innovative Medicine Israel in 2022. Johnson & Johnson is one of the leading pharmaceutical companies in the world. Liat brings 25 years of experience in the pharma industry both locally and globally, including 18 years at MSD Pharmaceuticals in Israel and Europe, where she served in various management and marketing roles.

Liat has extensive experience in managing diverse therapeutic areas, leading diverse units to achieve outstanding accomplishment based on a strong vision of innovation, creativity and outcome-driven leadership approach. Additionally, she has experience in shaping the environment, change management, and handling complex processes involving the Ministry of Health. Liat has also served as a commercial leader at the regional European level and has led global projects.

Inbar Grebler is Business Development Manager at MEDX Xelerator. For more than 10 years, Inbar has been involved in overseeing early-stage Israel investment in the medical field for international investors.

• Leads diverse projects such as establishment of an innovation centers in Israeli hospitals.
• Establishes medical ventures from idea stage to commercialization, from an entrepreneurial point of view, HMOs, and hospital institutes.
• Founded and managed a boutique consulting company in the field of medical innovation and the Chinese market.
• Holds an MBA in healthcare innovation from Reichman University and BA in Economics & Asia studies, specializing in Chinese from Tel Aviv University.

Ariel Hammerman is the Health Technology Assessment Director at Medison Pharma since May 2023, where he supports market access efforts of all Medison’s global affiliates.

Dr. Hammerman’s previous role was Head of Pharmaceutical Technology Assessment at Clalit Health Services Headquarters, since the year 2000. At Clalit, he was in charge of preparing Clalit's position towards the annual discussions on updating the National Health Basket, was a member of the Israeli Health Basket economic sub-committee and a member of Clalit’s institutional formulary board.

Besides his regular work, Dr. Hammerman also runs a course on cost-effectiveness analysis at Tel Aviv University Medical School. He has published over 50 scientific peer-reviewed publications with over 2000 citations, in different aspects of health economics and outcomes research. These include publications in the NEJM, The Lancet Infectious Diseases and in Nature Medicine regarding Covid-19 and monkeypox vaccines.

Senior VP, Global Head of Early Clinical Development, Innovative Medicines, R&D at Teva Pharmaceuticals. Eran is a medical doctor, board certified in psychiatry. He has over 19 years’ experience in senior global management and leadership roles in international large pharmaceutical companies and smaller biotech companies both in Israel and in the US (including Lundbeck and Pfizer Global Headquarters in New York, USA).

Eran is experienced in building R&D capabilities in artificial intelligence, machine learning and big data, to introduce broader use of digital technologies and to help drive efficiencies and improved outcomes in pharmaceutical R&D. Eran earned his MD degree from Tel Aviv University Faculty of Medicine, and later trained and practiced as a psychiatrist at Sheba Medical Center.

Hilik Harari has 28 years of international experience in early- and late-stage technology companies. Hilik holds extensive multidisciplinary experience in business development, marketing, product, and R&D.

Seasoned entrepreneur and strategist Mahmoud Khweis leverages his deep understanding of the region's socio-economic landscape for impactful ventures.

Author of Expertise: Khweis' published works, including two Harvard Business School-backed titles, showcase his management and public procurement expertise.

Beyond Authorship: His experience spans hi-tech research (Harvard Kennedy School), supply chain specialization, and ISO9001 QMSA Lead Auditor certification.

Extensive Experience: For two decades, Khweis has served with the United Nations, World Bank, USAID, British Council, and other esteemed organizations, Co-Chaired 5050startups, Member of the Board of Directors at the Azrieli College of Engineering, 

Entrepreneurial Spirit: Khweis leads Techlinic (R&D software) and Procure.ps (logistics), co-founded Jobpal (recruitment), and established Jinnovate (Jerusalem's first healthtech hub).

Moshe Klaiman is an healthcare-neer - innovator, technology seeker and curious, experienced manager of technology companies, and expert in transforming ideas to reality.

Dr. Stephen Klasko is a preeminent innovator, pursuing his passion to bridge traditional academic medicine with the emerging world of generative AI, digital medicine and entrepreneurship. In academic healthcare, he has been a dean of medicine, a CEO and a university president. Currently, he advises General Catalyst, the largest private investor in digital health. He is Chief Global Innovation Officer Sheba Medical Center and former President and CEO Jefferson University & Jefferson Health in Philadelphia.

Miki Levy is Co-Founder & CTO of XRHealth and GM of XRHealth IL. Miki holds a BSc in Chemical Engineering - Summa Cum Laude , and a Master of Military Operational Art and Science from the US Air University.

Miki co-founded XRHealth after a 16-year career as an executive officer and commander in the Israeli Air Force, where he used XR technology (VR/AR/MR) to develop new training strategies based on Full Mission Simulators and state-of-the-art computer-generated virtual environments. This experience turned him into a true believer in the disruptive potential of XR.

XRHealth is revolutionizing healthcare, bringing patient care into the Metaverse. The company operates state-of-the-art virtual clinics, utilizing proprietary FDA and CE registered medical Extended Reality (XR) technology (virtual and augmented reality). XRHealth integrates immersive XR technology, licensed clinicians, and real-time data analytics on one platform, providing a comprehensive therapeutic care solution for patients to receive treatment from the comfort of their homes. The company offers a variety of patented solutions for online mental health, occupational and physical health.

Prof. Meir (Iri) Liebergall is Professor of Orthopedic Surgery at the Hebrew University, Jerusalem. He serves as Outgoing Director of the Orthopedics Division. He is now serving as Medical Director of Orthopedic and Spinal Rehabilitation at Hadassah Medical Center. Under his leadership, the department has gained global recognition, particularly for advances in computer-assisted orthopedic surgery (CAOS) and its designation as a Center of Excellence.

Prof. Liebergall has been instrumental in pioneering robotic and minimally invasive surgical techniques, contributing to cutting-edge treatments in joint replacement, trauma surgery, and the integration of stem cells to accelerate recovery for severe fractures. He has also collaborated with various international and national organizations, including the American Academy of Orthopedic Surgeons and the AO Trauma community.

He was President of the Israel Orthopedic Assocaition, and currently serves as Chairman of the National Consulting Committee for Trauma & Emergency Medicine.

Tamara is the Data and AI Strategy Lead at Pfizer Oncology. She is accountable for creating and executing a Digital-First Oncology strategy that leverages AI and emerging technologies to accelerate the discovery and development of breakthrough oncology therapies, optimize R&D processes, and improve patient outcomes. Tamara and her team identify and prioritize AI opportunities, secure internal and external collaborations, and oversee the lifecycle of AI solutions from concept to deployment. In doing so, Tamara and her team are making a tangible impact on both Pfizer Oncology and its patients.

Previously, Tamara led a team in Digital Innovation & Alliances where she found and implemented digital innovation solutions in support of Pfizer's R&D Strategy.

Tamara has over 10 years of experience in R&D and Digital Portfolio Prioritization and has effectively collaborated across organizational boundaries to deliver asset and portfolio value.

Prior to joining Pfizer 20 years ago Tamara worked in management consulting focused tech and telecommunications. She received an MBA from the Johnson Business School at Cornell University in 2004.

Tamara enjoys working out, volunteering in her community, and spending time with her husband and three kids.

Dr. Shai Melcer is head of the National Bio-convergence Program, working with multiple partners in government to promote the field as an economic driver via excellence in multi-disciplinary R&D, specialized human capital and infrastructure, and regulatory policy.

Shai is also an associate lecturer of Biotechnology at the Hebrew University.

Previously, Shai has served as Co-founder of the GRAM Bio-Foundry; CBO at Minovia Therapeutics; CEO at BIOHOUSE; Executive Director of BioJerusalem (JDA); and Co-founder of BioGiv.

Shai has PhD and LLM degrees from the Hebrew University.

Dr. Dina Nir is a senior organizational consultant and researcher specializing in positive psychology and organizational transformation.

With a Ph.D. in Organizational Behavior from the Hebrew University of Jerusalem, she serves as the Head of the Executive MBA program at Ono Academic College and lectures at Reichman University.

Dr. Nir helps Israeli and international companies build positive, empowering ecosystems that foster excellence and continuous growth.

Merging academic research with practical applications, she has developed innovative management tools, including the GROW™ model of decision-making, the Feedforward interview for enhancing employee performance, and the Transformative Performance Appraisal™ for conducting effective annual evaluations. 

Dr. Idit Peretz is a medical oncologist and the head of a Rapid Diagnosis Clinic at the Davidoff Cancer Center. She completed her medical degree at the Hebrew University in Jerusalem in 2009 and her residency in 2018. Currently, she also leads the "Davidoff in Yoseftal- Eilat" project. Recently, Dr. Peretz earned an MBA from Tel Aviv University.

Partner, Chair of the IL Technology Transactions Practice Group, Pearl Cohen

With over 20 years of experience, Hili focuses on representing entrepreneurs and companies in licensing and technology transactions, including patent licensing, joint ventures, development, manufacturing, and distribution agreements. In addition, Hili handles corporate and commercial transactions, such as fundraising and mergers and acquisitions. She has been involved in and led securing legal engagements in a vast range of industries, including pharma, medical devices, food tech, clean energy, and more.

Shirley is a pediatrician and former TV producer dedicated to advancing child and adolescent healthcare. As Head of Innovation at Schneider Children’s Medical Center, she leads the "PedTech Playground", a sandbox for startups and a platform for entrepreneurs in pediatric innovation. Additionally, she oversees the Allied Health Professions sector while maintaining a Pediatric Clinic. Shirley is a proud member of women in medicine networks (Womed, WE@HealthTech) and spearheads projects aimed at enhancing medical care for teenage girls, with a focus on diagnosing teen endometriosis. She completed her residency at Schneider Children’s Medical Center, where she is now a Medical Administration Fellow.

Dr. Ortal Segal is an orthopedic surgeon at Tel Aviv Sourasky Medical Center (the national unit for orthopedic oncology) and at the Levin Center for Medical Innovation. With a strong focus on advancing orthopedic care through innovative technologies, Dr. Segal is dedicated to exploring new solutions that enhance patient outcomes. At the 2nd Summit of the Israeli Society for HealthTech (ISoH-Tech), Dr. Segal looks forward to sharing insights on the latest developments in orthopedic innovation and connecting with fellow professionals.

Dr. Shirley Shapira is a dedicated hematologist with extensive experience as a physician across various settings, including hospital care, community health, and within the regulatory system. She completed her medical studies at the Technion in Haifa, Israel. Afterward, she pursued residency training in internal medicine and a fellowship in hematology at Meir Hospital. Since 2003, Dr. Shapira has been serving as a consultant hematologist at Meir Hospital and at Maccabi Health Services.

Her primary research interest lies in exploring the connection between mind and body, particularly focusing on the potential of harnessing consciousness to enhance the healing process.

Noga Shiloach is Chief Product Officer at Startup Nation Central, an organization dedicated to addressing today’s most complex challenges by leveraging Israel’s bold and innovative tech ecosystem. Noga brings extensive experience from both the public and private sectors, with a strong background in strategy, finance, product management, innovation, and business development.

Before joining Startup Nation Central, she founded and led the TLV Innovation Hub at Boston Consulting Group, where she connected BCG’s global clients with the Israeli tech landscape. Prior to that, Noga served as VP of Products and Solutions at Leumi-Tech, the high-tech arm of Israel’s leading banking group. Her career began in Israel’s Ministry of Finance, where she oversaw large-scale government projects. Noga holds a BA in Business, Economics, and Communication, and an MBA, both Summa Cum Laude, from the Hebrew University of Jerusalem.

Dr. Abraham (Avi) Shina, LTC, earned his M.D. at The Technion Israel Institute of Technology, cum laude, then began his career serving public health.

In civilian life, Avi specialized in OB/GYN at Sheba Medical Center and earned his Master's in Health Systems Administration from Ben Gurion University. After he was recognized for executive leadership potential, he was selected for the elite Sheba Talpiot Medical Leadership Program, where today he develops innovative ideas for practicing medicine and administering healthcare.  Avi completed his Master's degree in public administration at Harvard university in 2022.

In the Israel Defense Forces, he has been a physician and a medical leader. Avi rose in combat medicine and command roles, from the battalion to the command level, managing thousands of medical personnel.

In his last role as the chief medical officer of the Central Command he oversaw combat casualty care as well as primary care provision and medical force buildup across the command.    

Currently, he is Head of the Mashrap, the IDF medical corps center for healthcare services in charge of primary, specialty and rehabilitative care in the IDF as well as the healthcare policymaking.   

Avi is a researcher and senior lecturer in the Hebrew University faculty of medicine.

A certified Pediatrician, Dr. Siegal serves as the Head of the Medical Technologies Division at Maccabi HMO. Her former positions include Head of the Medical Division, leading Maccabi’s strategy, and serving as VP of Quality and Strategy at Hadassah Medical Center.

Dr. Siegal also leads the MBA Health Management Specialty at Ono Academic College, and serves as the Health Management Society’s secretary.

Dr. Siegal holds MD degree from Tel Aviv University as well as MPA from Harvard.

Danny Spiegelstein MD is UltraSight’s VP Medical. Dr. Spiegelstein has 20+ years of medical experience in cardiovascular invasive medicine. He is an experienced clinical research investigator, managing protocols and operations in compliance with GMP and other regulatory requirements. Prior to UltraSight, Dr. Spiegelstein served as a consultant for medical start-ups in cardiology.

Amir Szold MD, FSA is a pioneer laparoscopic surgeon, trained in surgery in Hadassah Medical Center in Jerusalem and Mount Sinai Medical Center New York. In the late 90’s he was Founder and the first President of the Israeli Society of Endoscopic Surgery. He was recently a board member, and Technology Committee Chairman of the European Association of Endoscopic Surgeons, and board member of the Israeli Society of Surgeons. He currently serves on the steering committee of iSMIT, and is a member of the Technology Committee of SAGES. Dr. Szold is currently a Clinical Professor of Surgery at Sheba Medical Center and the Tel Aviv University School of Medicine.

Dr. Szold’s main clinical fields are hernia surgery, upper GI, solid organ surgery and bariatric surgery.

He is heavily involved in medical innovation, serving as founder, advisor and board member for multiple medical device startup companies in Israel and Europe, covering fields of 3D vision, robotics, soft tissue replacements, surgical glues, laser technology, smart materials and laparoscopic devices. He is also Founder and Medical director of Assia Medical Group in Tel Aviv, and Founder and current advisor of the Physicians for Human Rights volunteer clinic for illegal immigrants and refugees, Tel Aviv, Israel.

Dr. Michal Tsur is a serial entrepreneur. She is co-founder and co-CEO of Remepy, the pioneer of hybrid drugs. Prior to Remepy, Michal was co-founder and president of Kaltura (Nasdaq: KLTR), the video experience cloud. Prior to Kaltura, Michal co-founded Cyota, provider of security and anti-fraud solutions for financial institutions (acquired by RSA Security (Nasdaq: RSAS)). Michal holds a doctoral degree from NYU and was a post-doctoral fellow at Yale’s Information Society Project. Michal loves to run, swim and hike, and regularly blogs and writes.

Dr. Hedva Voliovitch is Co-founder and Chair of the Israeli Society for HealthTech and serves on the board of Maccabi Healthcare Services and Bayit Balev.

Hedva established Global Pharmacovigilance and Patient Safety at Teva Pharmaceuticals and served as Senior Vice President at the company. She consults for biotech companies on drug development, drug safety and pharmacovigilance, and on intrapreneurship. Board-certified in Internal Medicine, she has also worked as a practicing physician for 20 years.

She has an MD degree from Tel Aviv University Faculty of Medicine, a PhD in Molecular Biology from the Weizmann Institute of Science and an MBA – Global Management from Reichman University (IDC).

She is member of 8400 Health Network.

Dr. Rinat Yedidya is the Deputy Director of the Open Psychiatric Ward at SHALVATA Mental Health Center. A graduate of Tel Aviv University Medical School through the IDF Academic Reserves, Dr. Yedidya has extensive experience in mental health care and works to ensure high standards of patient care and ward management. In addition to her role in SHALVATA, Dr. Yedidya is the founder and administrator of the "Women Doctors Room" Facebook community, fostering a supportive network for female medical professionals.

Sharon is the Director of NATAL Global, a subsidiary of NATAL - an Israeli NGO spearheading trauma treatment and resiliency development. As part of this position, Sharon develops international collaborations and exports NATAL's best practices and expertise to international stakeholders, helping communities and organizations get the tools they need to build personal and organizational resilience.

Sharon has Bachelor's and Master's degrees in International Relations with a specialization in International Law. She has extensive knowledge and experience in creating international collaborations and leading international projects for social impact.

CEO of Tzafon Medical Center (Poriya) and a senior lecturer at Bar Ilan University Faculty of Medicine.

Dr. Yehudai served as Deputy Director of Tzafon MC for two years before assuming the role of CEO.

In his previous roles, he was Deputy Director of Bnai Zion MC, Head of the ENT service in the IDF, a senior physician in the ENT Department at Bnai Zion MC, and as a senior lecturer at the Technion Faculty of Medicine.

Dr. Yehudai is a graduate of the Hebrew University - Hadassah Medical School, a specialist in Otolaryngology-Head and Neck Surgery, and in Medical Administration. He holds an MHA in Health Systems Management and an MBA. Additionally, Dr. Yehudai is a graduate of the "Inbar" Program of the Ministry of Health and Maoz.

Arnon Zangvil specializes in healthcare MLOps, medical device connectivity & cloud security, and has architected analytics platforms for both medical device startups and large leading multi-nationals.

Nimrod Zilcha is Co-founder and CEO of Cognishine, where he has been leading the company for over four years, driving the digital transformation of the standard of care for allied health professionals, with a focus on medium to large organizations. With more than 20 years of experience in business and finance, Nimrod combines entrepreneurial vision with strategic leadership to deliver accessible, personalized, and evidence-based therapy platform.

Under Nimrod's leadership, Cognishine enables synchronous and asynchronous, remote and in-person, group, and one-to-many sessions, providing flexible and comprehensive solutions for therapy delivery. A dedicated advocate for advancing speech and cognitive rehabilitation, Nimrod leverages cutting-edge technology and data-driven insights to reshape therapy delivery on a global scale.

Nimrod holds an MBA in Business Administration and has a proven track record of driving growth and innovation across various sectors.